Bone Cancer TumorNCT05746910
Patient's Perception of Exercise After Bone Tumor Resection-A Qualitative Study
An observational study of Bone Cancer Tumor, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to investigate the opinions of patients who have undergone bone tumor resection surgery about post-op exercises. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Bone Cancer Tumor
- How many people
- 10 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 5 Dec 2022to 10 Apr 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Adult, Older adult
Study population: Individuals who have been diagnosed with a bone tumor for the first time and who have undergone resection surgery
Who may be able to join
- Individuals aged between 18 and 65,
- Individuals without communication problems,
- Individuals who have been diagnosed with a bone tumor for the first time and who have undergone resection surgery
- Patients who have previously received therapeutic exercises
Who cannot join
- Uncontrollable arrhythmia and/or hypertension
- Presence of advanced sensory deficit
- Visual and hearing problems
- Not having sufficient communication skills (Mini-Mental Test score below 24 points)
- Patients undergoing head and neck bone resection
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Emel Mete
Istanbul, 34000
emel mete, MSc, 05376096265, e_emel86@hotmail.com
Nilufer Kablan, PhD
About this study
The aim of this study is to investigate the opinions of patients who have undergone bone tumor resection surgery about post-op exercises.
Read the detailed description
Semi-structured in-depth individual interviews will be conducted with patients who have undergone bone tumor surgery. In in-depth individual interviews, the same questions will be asked to all participants and the verbal answers to these questions will be recorded with voice recorders. Compared to taking notes by hand; It will be preferable to record the conversation with a voice recorder because it has advantages such as recording all the interviews and allowing the interviewer to focus on the interview. Thematic analysis method will be used in the evaluation of the data.
- Conditions
- Bone Cancer Tumor
- Keywords
- bone cancer tumor, exercise, Patient
- Medical subject headings
- Motor Activity
What is being measured
The primary outcome is the main question the study is designed to answer.
Semi-structured in-depth individual interviews about Patient's Perceptions of post-op exercises
Semi-structured in-depth individual interviews will be conducted with patients only once. The same questions will be asked to all participants and the verbal answers to these questions will be recorded with voice recorders.
Measured: baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Feb 2023
- Study start5 Dec 2022
- Primary completion30 Mar 2023 (estimated)
- Study completion10 Apr 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bone Cancer TumorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istanbul Medeniyet University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Emel Mete, Istanbul Medeniyet University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05746910
- Sponsor's protocol ID
- 2022/0179-1
- Status last verified
- Feb 2023
- First submitted
- 17 Feb 2023
- Last updated
- 28 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient's Perception of Exercise After Bone Tumor Resection-A Qualitative Study
- ClinicalTrials.gov ID
- NCT05746910
- Acronym / sponsor ID
- 2022/0179-1
- Conditions
- Bone Cancer Tumor
- Keywords
- bone cancer tumor, exercise, Patient
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Istanbul Medeniyet UniversityUniversity, hospital or other
- Study start
- 5 Dec 2022 (actual)
- Primary completion
- 30 Mar 2023 (estimated)
- Study completion
- 10 Apr 2023 (estimated)
- First posted
- 28 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to investigate the opinions of patients who have undergone bone tumor resection surgery about post-op exercises.
Detailed description
Semi-structured in-depth individual interviews will be conducted with patients who have undergone bone tumor surgery. In in-depth individual interviews, the same questions will be asked to all participants and the verbal answers to these questions will be recorded with voice recorders. Compared to taking notes by hand; It will be preferable to record the conversation with a voice recorder because it has advantages such as recording all the interviews and allowing the interviewer to focus on the interview. Thematic analysis method will be used in the evaluation of the data.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Individuals who have been diagnosed with a bone tumor for the first time and who have undergone resection surgery
Key inclusion criteria (4 listed)
- Individuals aged between 18 and 65,
- Individuals without communication problems,
- Individuals who have been diagnosed with a bone tumor for the first time and who have undergone resection surgery
- Patients who have previously received therapeutic exercises
Key exclusion criteria (5 listed)
- Uncontrollable arrhythmia and/or hypertension
- Presence of advanced sensory deficit
- Visual and hearing problems
- Not having sufficient communication skills (Mini-Mental Test score below 24 points)
- Patients undergoing head and neck bone resection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Semi-structured in-depth individual interviews about Patient's Perceptions of post-op exercises
Time frame: baseline
Semi-structured in-depth individual interviews will be conducted with patients only once. The same questions will be asked to all participants and the verbal answers to these questions will be recorded with voice recorders.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2023.
- Individual participant dataSharing planned: No
Related trials for Bone Cancer Tumor
RecruitingPhase 1
Vididencel in CML-CP Patients With MRD
CML (Chronic Myelogenous Leukemia)
RecruitingPhase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
RecruitingPhase 1/2
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Active, not recruitingPhase 2
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
RecruitingObservational study
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Leukemia, Lymphoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bone Cancer Tumor, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Semi-structured in-depth individual interviews about Patient's Perceptions of post-op exercises (time frame: baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2023.